Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
暂无分享，去创建一个
Deepak L. Bhatt | R. Diaz | H. White | A. Budaj | J. Jukema | R. Lopes | S. Goodman | R. Harrington | A. Zeiher | M. Roe | V. Bittner | P. Steg | A. Ristic | H. Colhoun | J. Murín | G. Schwartz | K. Ray | M. Szarek | A. Moryusef | J. Tuñón | R. Pordy | M. Baccara-Dinet | C. Hanotin | V. Loizeau